Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGS2 | P35354 | 8/20 | 0.59 |
| ▸ | PTGS1 | P23219 | 7/20 | 0.59 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.59 |
| ▸ | HTT | P42858 | 1/20 | 0.59 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.59 |
| ▸ | DDB1 | Q16531 | 1/20 | 0.53 |
| ▸ | CRBN | Q96SW2 | 1/20 | 0.53 |
| ▸ | HSD11B1 | P28845 | 1/20 | 0.47 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.47 |
| ▸ | PSEN1 | P49768 | 1/20 | 0.45 |
| ▸ | PSEN2 | P49810 | 1/20 | 0.45 |
| ▸ | APH1B | Q8WW43 | 1/20 | 0.45 |
| ▸ | NCSTN | Q92542 | 1/20 | 0.45 |
| ▸ | APH1A | Q96BI3 | 1/20 | 0.45 |
| ▸ | PSENEN | Q9NZ42 | 1/20 | 0.45 |
| ▸ | NOS3 | P29474 | 1/20 | 0.45 |
| ▸ | NOS1 | P29475 | 1/20 | 0.45 |
| ▸ | NOS2 | P35228 | 1/20 | 0.45 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.45 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23056654 | 1.00 | PTGS2 (0.59) | PTGS2PTGS1OPRK1HTTKMT2A | |
| SCHEMBL29169544 | 1.00 | PTGS2 (0.59) | PTGS2PTGS1OPRK1HTTKMT2A | |
| SCHEMBL29169546 | 0.94 | PTGS2 (0.57) | PTGS2PTGS1OPRK1HTTKMT2A | |
| SCHEMBL4595 | 0.94 | PTGS2 (0.57) | PTGS2PTGS1OPRK1HTTKMT2A | |
| SCHEMBL9790769 | 0.94 | PTGS2 (0.57) | PTGS2PTGS1OPRK1HTTKMT2A | |
| SCHEMBL7338783 | 0.93 | PTGS2 (0.56) | PTGS2PTGS1OPRK1HTTKMT2A | |
| SCHEMBL225031 | 0.93 | PTGS2 (0.56) | PTGS2PTGS1OPRK1HTTKMT2A | |
| SCHEMBL9144882 | 0.90 | PTGS2 (0.57) | PTGS2PTGS1OPRK1HTTKMT2A | |
| SCHEMBL29016897 | 0.88 | DDB1 (0.61) | PTGS2PTGS1OPRK1HTTKMT2A | |
| SCHEMBL9145459 | 0.86 | PTGS2 (0.54) | PTGS2PTGS1OPRK1HTTKMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 93 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117720408-A | Continuous flow preparation method of 2-benzyl cyclopentanone | 复旦大学 | 2024-03-19 | — | — | CN | claimed |
| CN-116042000-B | Coated controlled release fertilizer utilizing visible light to solidify aquatic wastes and preparation method thereof | 山东农业大学 | 2023-11-28 | — | — | CN | claimed |
| CN-116042000-A | Coated controlled release fertilizer utilizing visible light to solidify aquatic wastes and preparation method thereof | 山东农业大学 | 2023-05-02 | — | — | CN | claimed |
| CN-218689407-U | 2- [4- (2-chloropropionyl) benzyl ] cyclopentanone production device | 无棣融川医药化工科技有限公司 | 2023-03-24 | — | — | CN | claimed |
| CN-218306215-U | Production device of 2-benzyl cyclopentanone product | 无棣融川医药化工科技有限公司 | 2023-01-17 | — | — | CN | claimed |
| CN-113387787-A | Synthesis method of 2-benzyl cyclopentanone | 杭州国瑞生物科技有限公司 | 2021-09-14 | — | — | CN | claimed |
| WO-2012036822-A1 | PHENOL AND CYCLOHEXANONE MIXTURES | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2012-03-22 | — | — | WO | claimed |
| JP-9323954-A | — | — | None | — | — | JP | disclosed |
| CN-117720503-A | Continuous flow preparation method for catalyzing ketal reaction by strongly acidic ion resin | 复旦大学 | 2024-03-19 | — | — | CN | disclosed |
| CN-117720408-A | Continuous flow preparation method of 2-benzyl cyclopentanone | 复旦大学 | 2024-03-19 | — | — | CN | disclosed |
| CN-117720408-A | Continuous flow preparation method of 2-benzyl cyclopentanone | 复旦大学 | 2024-03-19 | — | — | CN | disclosed |
| CN-117720408-A | Continuous flow preparation method of 2-benzyl cyclopentanone | 复旦大学 | 2024-03-19 | — | — | CN | disclosed |
| CN-117701516-A | Alkene reductase, enzyme preparation, nucleic acid, expression vector, preparation method and application | 河北工业大学 | 2024-03-15 | — | — | CN | disclosed |
| WO-2011100013-A1 | HYDROGENATION PROCESS | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2011-08-18 | — | — | WO | disclosed |
| US-20110124877-A1 | 5-BENZYL-4-AZOLYLMETHYL-4-SPIRO[2.4]HEPTANOL DERIVATIVES, METHODS FOR PRODUCING THE SAME, AND AGRO-HORTICULTURAL AGENTS AND INDUSTRIAL MATERIAL PROTECTING AGENTS THEREOF | KUREHA CORPORATION (JP) | 2011-05-26 | — | — | US | disclosed |
| EP-1103255-B1 | METHOD OF REARING AND FEEDS | TAKARA BIO INC (JP) | 2007-05-02 | — | — | EP | disclosed |
| WO-2001017977-A1 | 1,3,5-TRIAZINES AS HERBICIDES | NIHON BAYER AGROCHEM K.K. (JP) | 2001-03-15 | — | — | WO | disclosed |
| JP-H09323954-A | PRODUCTION OF (+-) 2-(4-(2-OXOCYCLOPENTYLMETHYL) PHENYL) PROPIONIC ACID AND ITS SALT | CHEMI SPA | 1997-12-16 | — | — | JP | disclosed |
| US-5281622-A | Administering to mammals as antiinflammatory agent | UNIVERSITY OF PITTSBURGH OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION (US) | 1994-01-25 | — | — | US | disclosed |
| US-5250735-A | Antitumor or antiinflammatory agents, analgesics | UNIVERSITY OF PITTSBURGH (US) | 1993-10-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110124877-A1 | 5-BENZYL-4-AZOLYLMETHYL-4-SPIRO[2.4]HEPTANOL DERIVATIVES, METHODS FOR PRODUCING THE SAME, AND AGRO-HORTICULTURAL AGENTS AND INDUSTRIAL MATERIAL PROTECTING AGENTS THEREOF | CYP8B1, CBR3, CBR1 | PTGS2 1120/4885PTGS1 1320/4885OPRK1 4117/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.